Add to ORKGClinical trials including an analytical treatment interruption (ATI) are vital for evaluating the efficacy of novel strategies for HIV remissions. We briefly describe an interactive tool for predicting viral rebound timing in ATI trials and the impact of posttreatment controller (PTC) definitions on PTC frequency estimates. A 4-week viral load threshold of 1000 cps/ml provides both high specificity and sensitivity for PTC detection. PTC frequency varies greatly based on the definition of a PTC
BackgroundDevelopment of human immunodeficiency virus (HIV) remission strategies requires precise in...
Objective(s)The short-term safety of treatment interruptions, a necessary part of cure studies, is n...
HIV post-treatment controllers (PTCs) are rare individuals who maintain low levels of viremia after ...
Clinical trials including an analytical treatment interruption (ATI) are vital for evaluating the ef...
BackgroundHIV posttreatment controllers are rare individuals who start antiretroviral therapy (ART),...
Background: HIV posttreatment controllers are rare individuals who start antiretroviral therapy (ART...
Background. HIV posttreatment controllers are rare individuals who start antiretroviral therapy (ART...
International audienceThe posttreatment controllers (PTCs), as described for the Viro-Immunological ...
Objective(s): An HIV cure will impose aviraemia that is sustained following the withdrawal of antire...
One approach to 'functional cure' of HIV infection is to induce durable control of HIV replication a...
Monitoring the efficacy of novel reservoir-reducing treatments for HIV is challenging. The limited a...
International audienceAn important challenge of HIV research today is ‘functional cure’ or HIV remis...
Antiretroviral therapy (ART) effectively controls HIV infection, suppressing HIV viral loads. Suspen...
Monitoring the efficacy of novel reservoir-reducing treatments for HIV is challenging. The limited a...
Introduction: Viral remission after analytical treatment interruption (ATI), termed post-treatment c...
BackgroundDevelopment of human immunodeficiency virus (HIV) remission strategies requires precise in...
Objective(s)The short-term safety of treatment interruptions, a necessary part of cure studies, is n...
HIV post-treatment controllers (PTCs) are rare individuals who maintain low levels of viremia after ...
Clinical trials including an analytical treatment interruption (ATI) are vital for evaluating the ef...
BackgroundHIV posttreatment controllers are rare individuals who start antiretroviral therapy (ART),...
Background: HIV posttreatment controllers are rare individuals who start antiretroviral therapy (ART...
Background. HIV posttreatment controllers are rare individuals who start antiretroviral therapy (ART...
International audienceThe posttreatment controllers (PTCs), as described for the Viro-Immunological ...
Objective(s): An HIV cure will impose aviraemia that is sustained following the withdrawal of antire...
One approach to 'functional cure' of HIV infection is to induce durable control of HIV replication a...
Monitoring the efficacy of novel reservoir-reducing treatments for HIV is challenging. The limited a...
International audienceAn important challenge of HIV research today is ‘functional cure’ or HIV remis...
Antiretroviral therapy (ART) effectively controls HIV infection, suppressing HIV viral loads. Suspen...
Monitoring the efficacy of novel reservoir-reducing treatments for HIV is challenging. The limited a...
Introduction: Viral remission after analytical treatment interruption (ATI), termed post-treatment c...
BackgroundDevelopment of human immunodeficiency virus (HIV) remission strategies requires precise in...
Objective(s)The short-term safety of treatment interruptions, a necessary part of cure studies, is n...
HIV post-treatment controllers (PTCs) are rare individuals who maintain low levels of viremia after ...